Cetera Investment Advisers
SNY icon

Cetera Investment Advisers’s Sanofi SNY Stock Holding History

Cetera Investment Advisers’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Sell
266,372
-95,189
-26% -$4.25M 0.01% 1076
2026
Q1 		$17.4M Buy
361,561
+43,135
+14% +$2.01M 0.02% 747
2025
Q4 		$15.4M Buy
318,426
+14,641
+5% +$726K 0.02% 785
2025
Q3 		$14.3M Buy
303,785
+61,746
+26% +$2.98M 0.02% 800
2025
Q2 		$11.7M Buy
242,039
+16,960
+8% +$867K 0.02% 743
2025
Q1 		$12.5M Buy
225,079
+25,941
+13% +$1.4M 0.02% 668
2024
Q4 		$9.6M Buy
199,138
+9,818
+5% +$499K 0.02% 719
2024
Q3 		$10.9M Buy
189,320
+1,161
+0.6% +$62.7K 0.02% 667
2024
Q2 		$9.13M Buy
188,159
+9,810
+6% +$473K 0.02% 709
2024
Q1 		$8.67M Buy
178,349
+126,712
+245% +$6.19M 0.02% 719
2023
Q4 		$2.57M Sell
51,637
-12,207
-19% -$597K 0.02% 690
2023
Q3 		$3.42M Buy
63,844
+2,505
+4% +$134K 0.03% 546
2023
Q2 		$3.31M Buy
61,339
+8,627
+16% +$464K 0.03% 569
2023
Q1 		$2.87M Buy
52,712
+22,807
+76% +$1.11M 0.03% 592
2022
Q4 		$1.45M Buy
29,905
+11,453
+62% +$503K 0.01% 832
2022
Q3 		$702K Sell
18,452
-136
-0.7% -$6.06K 0.01% 857
2022
Q2 		$930K Sell
18,588
-194
-1% -$10.3K 0.01% 822
2022
Q1 		$964K Buy
18,782
+1,424
+8% +$73.5K 0.01% 835
2021
Q4 		$870K Buy
17,358
+259
+2% +$12.8K 0.01% 868
2021
Q3 		$824K Buy
17,099
+47
+0.3% +$2.39K 0.01% 853
2021
Q2 		$898K Buy
17,052
+3,801
+29% +$198K 0.01% 820
2021
Q1 		$655K Sell
13,251
-4,553
-26% -$219K 0.01% 842
2020
Q4 		$865K Buy
+17,804
New +$878K 0.02% 723
2017
Q4 		– Sell
-4,599
Closed -$229K – 418
2017
Q3 		$229K Buy
4,599
+100
+2% +$4.84K 0.05% 347
2017
Q2 		$215K Sell
4,499
-493
-10% -$23.6K 0.05% 346
2017
Q1 		$227K Buy
+4,992
New +$212K 0.06% 319

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Cetera Investment Advisers's SNY Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Sanofi (SNY) stake by 26% in Q2 2026, selling an estimated $4.25M and leaving 266,372 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #1076.

Cetera Investment Advisers first reported a position in SNY in Q1 2017 and has held it in 26 quarters since. The position peaked at $17.4M in Q1 2026. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cetera Investment Advisers held 266,372 shares of Sanofi worth $11.4M as of Q2 2026.
  • Cetera Investment Advisers sold 95,189 Sanofi shares in Q2 2026, an estimated $4.25M.
  • Sanofi made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1076 holding.
  • Cetera Investment Advisers first reported a position in Sanofi in Q1 2017 and has held it in 26 quarters since.
  • Cetera Investment Advisers's Sanofi position peaked at $17.4M in Q1 2026.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.